Literature DB >> 21474617

Arrhythmias in chronic kidney disease.

Paul R Roberts1, Darren Green.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21474617     DOI： 10.1136/hrt.2010.208587

Source DB:  PubMed          Journal:  Heart        ISSN： 1355-6037            Impact factor:   5.994


× No keyword cloud information.
  12 in total

Review 1.  Mechanisms of sudden cardiac death: oxidants and metabolism.

Authors:  Kai-Chien Yang; John W Kyle; Jonathan C Makielski; Samuel C Dudley
Journal:  Circ Res       Date:  2015-06-05       Impact factor: 17.367

2.  Shades of grey: the conundrum of implantable defibrillators in individuals with advanced CKD.

Authors:  Aisha Khattak; David M Charytan
Journal:  Clin J Am Soc Nephrol       Date:  2015-06-25       Impact factor: 8.237

3.  Rates of Cardiac Rhythm Abnormalities in Patients with CKD and Diabetes.

Authors:  Nazem Akoum; Leila R Zelnick; Ian H de Boer; Irl B Hirsch; Dace Trence; Connor Henry; Nicole Robinson; Nisha Bansal
Journal:  Clin J Am Soc Nephrol       Date:  2019-03-19       Impact factor: 8.237

4.  Klotho and phosphate are modulators of pathologic uremic cardiac remodeling.

Authors:  Ming Chang Hu; Mingjun Shi; Han Jun Cho; Beverley Adams-Huet; Jean Paek; Kathy Hill; John Shelton; Ansel P Amaral; Christian Faul; Masatomo Taniguchi; Myles Wolf; Markus Brand; Masaya Takahashi; Makoto Kuro-O; Joseph A Hill; Orson W Moe
Journal:  J Am Soc Nephrol       Date:  2014-10-17       Impact factor: 10.121

5.  Chronic kidney disease in patients with cardiac rhythm disturbances or implantable electrical devices: clinical significance and implications for decision making-a position paper of the European Heart Rhythm Association endorsed by the Heart Rhythm Society and the Asia Pacific Heart Rhythm Society.

Authors:  Giuseppe Boriani; Irina Savelieva; Gheorghe-Andrei Dan; Jean Claude Deharo; Charles Ferro; Carsten W Israel; Deirdre A Lane; Gaetano La Manna; Joseph Morton; Angel Moya Mitjans; Marc A Vos; Mintu P Turakhia; Gregory Y H Lip
Journal:  Europace       Date:  2015-06-24       Impact factor: 5.214

6.  Impact of chronic kidney disease on mortality in older adults treated with pacemaker implantation.

Authors:  Fabio Fabbian; Alfredo De Giorgi; Matteo Guarino; Michele Malagù; Matteo Bertini
Journal:  J Geriatr Cardiol       Date:  2017-10       Impact factor: 3.327

Review 7.  Uremic Toxins and Their Relation with Oxidative Stress Induced in Patients with CKD.

Authors:  Anna Pieniazek; Joanna Bernasinska-Slomczewska; Lukasz Gwozdzinski
Journal:  Int J Mol Sci       Date:  2021-06-08       Impact factor: 5.923

8.  Association between serum soluble urokinase-type plasminogen activator receptor and atrial fibrillation.

Authors:  Noboru Ichihara; Masatoshi Miyamura; Daichi Maeda; Tomohiro Fujisaka; Shu-Ichi Fujita; Hideaki Morita; Yoshihiro Takeda; Takahide Ito; Koichi Sohmiya; Masaaki Hoshiga; Nobukazu Ishizaka
Journal:  J Arrhythm       Date:  2017-05-30

Review 9.  Cardiotoxicity of Uremic Toxins: A Driver of Cardiorenal Syndrome.

Authors:  Suree Lekawanvijit
Journal:  Toxins (Basel)       Date:  2018-09-01       Impact factor: 4.546

Review 10.  Clinical Potential of Targeting Fibroblast Growth Factor-23 and αKlotho in the Treatment of Uremic Cardiomyopathy.

Authors:  Jonathan P Law; Anna M Price; Luke Pickup; Ashwin Radhakrishnan; Chris Weston; Alan M Jones; Helen M McGettrick; Winnie Chua; Richard P Steeds; Larissa Fabritz; Paulus Kirchhof; Davor Pavlovic; Jonathan N Townend; Charles J Ferro
Journal:  J Am Heart Assoc       Date:  2020-03-26       Impact factor: 5.501
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.